Clients
hVIVO plc (formerly Open Orphan plc)
hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
Yamin 'Mo' Khan, Chief Executive Officer, and Stephen Pinkerton, Chief Financial Officer, will provide a live presentation relating to the interim results via the Investor Meet Company platform on Tuesday 23 September 2025 at 6.00pm BST.
Investors can sign up to Investor Meet Company for free and add to meet hVIVO here
Event | Date |
Year End | 31 December |
Half Year End | 30 June |
Preliminary Results* | April |
Interim Results* | September |
AGM* | May |
* Months based on previous announcements of this kind


Leave a comment

Who We Work With
hVIVO plc (formerly Open Orphan plc)
hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
Yamin 'Mo' Khan, Chief Executive Officer, and Stephen Pinkerton, Chief Financial Officer, will provide a live presentation relating to the interim results via the Investor Meet Company platform on Tuesday 23 September 2025 at 6.00pm BST.
Investors can sign up to Investor Meet Company for free and add to meet hVIVO here
Event | Date |
Year End | 31 December |
Half Year End | 30 June |
Preliminary Results* | April |
Interim Results* | September |
AGM* | May |
* Months based on previous announcements of this kind

